SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-340320
Filing Date
2021-11-24
Accepted
2021-11-24 16:06:39
Documents
8
Effectiveness Date
2021-11-24

Document Format Files

Seq Description Document Type Size
1 S-3ASR d249131ds3asr.htm S-3ASR 327896
2 EX-1.2 d249131dex12.htm EX-1.2 191277
3 EX-4.3 d249131dex43.htm EX-4.3 281336
4 EX-5.1 d249131dex51.htm EX-5.1 26367
5 EX-23.2 d249131dex232.htm EX-23.2 1269
6 GRAPHIC g249131g09f17.jpg GRAPHIC 2953
7 GRAPHIC g249131g22s22.jpg GRAPHIC 35072
8 GRAPHIC g249131g68k04.jpg GRAPHIC 2796
  Complete submission text file 0001193125-21-340320.txt   881526
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-261344 | Film No.: 211446470
SIC: 2834 Pharmaceutical Preparations